The Medicines Company
is a biopharmaceutical company that researches and develops therapeutics for the treatment of cardiovascular diseases... Read moreThe Medicines Company
is a biopharmaceutical company that researches and develops therapeutics for the treatment of cardiovascular diseases... Read more
News
Jan 09, 2020
Business Medical Dialogues
The Medicines Company: Novartis successfully completes acquisition of The Medicines Company, adding a potentially first-in-class, investigational cholesterol-lowering therapy inclisiran
Dec 20, 2019
FierceBiotech
The Medicines Company: News of Note-Novartis backs out of Akcea/Ionis research deal; Flagship jumps on gene therapy bandwagon
Dec 18, 2019
Seeking Alpha
The Medicines Company: With Positive Phase III Data From Lumasiran, Alnylam On Track For Another Approval
Dec 13, 2019
BioPortfolio
The Medicines Company: A new cholesterollowering drug developed by MDCONews under license from Alnylam could soon be under review with the US FDA and an approval appears likely httpstwitter.comNatureBiotechstatus1202968187903582208Â
Dec 05, 2019
FinanzNachrichten
The Medicines Company: Novartis Commences Tender Offer For Medicines Company
Dec 02, 2019
MarketScreener
The Medicines Company: Monteverde & Associates PC Announces an Investigation of TD AMERITRADE HOLDING CORPORATION - AMTD
Dec 01, 2019
Insider Monkey
The Medicines Company: Hedge Funds Hit The Bullseye With This Stock Pick
Nov 26, 2019
firstwordpharma
The Medicines Company: Biotech Rallies as Novartis's $9.7 Billion Deal Revives Optimism - (Bloomberg via NewsPoints Desk)
Nov 25, 2019
Investor’s Business Daily
The Medicines Company: Novartis' Takeover Of Medicines Puts The Spotlight On These Biotechs
Nov 25, 2019
24/7 Wall St.
The Medicines Company: Novartis Finally Comes Through With Its Acquisition of Medicines Co
The Medicines Company Competitors
1
2
3
4
5
6
7
8
9
10